Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 11 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 12083192

    Methods for treatment of patients with myelodysplastic syndromes

    Actinium Phamaceuticals, Inc. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  2. US 12084515

    Compositions and methods for treatment of diabetic macular edema

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  3. US 12083184

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  4. US 12077515

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  5. US 12076324

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  6. US 12076332

    Treatment of lysosomal storage disorders

    The Regents of the University of California · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  7. US 12077760

    DNA aptamers and use thereof for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  8. US 12070472

    Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds

    The Board of Regents of the University of Texas System · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  9. US 12070509

    Nucleic acids and methods of treatment for cystic fibrosis

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  10. US 12072338

    Pharmaceutical peptides for the treatment of inflammatory diseases

    PROTAGONISTS LTD. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  11. US 12064507

    Composition and method for oral treatment of leukemia

    Provectus Pharmatech, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  12. US 12065485

    Treatment of staphylococcal disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  13. US 12064399

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  14. US 12060558

    Methods and compositions for treatment of cholesteryl ester storage disease

    STOKE THERAPEUTICS, INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  15. US 12061206

    Diagnosis and treatment of autoimmune diseases

    Takeda Pharmaceutical Company Limited · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  16. US 12060555

    MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

    UNIVERSITY OF CONNECTICUT · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  17. US 12059214

    System and method of performing treatment along a lumen network

    Covidien LP · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  18. US 12059418

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  19. US 12054553

    Immunotherapeutic tumor treatment method

    Nektar Therapeutics · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  20. US 12053526

    Methods for treatment using anti-alpha4beta7 antibody

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  21. US 12053455

    Antigen-driven detection and treatment of coccidioidomycosis

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  22. US 12053531

    Materials and methods for treatment of Duchenne Muscular Dystrophy

    Vertex Pharmaceuticals Incorporated · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  23. US 12048699

    Cancer treatment methods based on TP53 mutation status and hypermutation

    Takeda Pharmaceutical Company Limited · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  24. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted